Skip to main content
Premium Trial:

Request an Annual Quote

Andrew Marion, Jeff Whitmore

Biomarker diagnostics developer Singulex has added Andrew Marion to its board of directors, the company said last week.
 
Marion is the founder of Applied Biosystems. He is currently a director at Molecular Devices, Applied Imaging, Alpha M.O.S., and Guava Technologies.
 
He was CEO at ABI for seven years and was chairman of the board for six, after which he served as vice president at PerkinElmer.
 

 
Alpha Innotech has hired Jeff Whitmore to be the new vice president of the company’s global sales department, the company announced last week.
 
Whitmore was recently director of European life science sales for Molecular Devices. Before that he was involved in US sales at Molecular Devices and at BioRad Laboratories.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.